ANGO
AngioDynamics Inc
15.40$
+0.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 20.1% | 20.1% | 21.7% | 23.8% | 37.7% | 25.7% | 25.1% | 25.9% | 30.7% | 60.8% | 60.1% | 61.2% | |
| 2.4% | 4.4% | 6.7% | 10.5% | 27.2% | 9.1% | 8.6% | 5.2% | 8.4% | 23.9% | 20.0% | 20.2% | |
| 2.6% | 4.7% | 6.9% | 10.7% | 27.2% | 9.1% | 8.6% | 5.2% | 8.4% | 23.9% | 20.0% | 20.2% | |
| 7.6% | 7.3% | 6.5% | 5.6% | 5.2% | 5.7% | 6.3% | 10.2% | 9.9% | 15.7% | 15.4% | 18.1% | |
| 8.7% | 7.6% | 7.7% | 5.6% | 4.8% | 10.1% | 8.7% | 9.3% | 10.4% | 19.1% | 22.1% | 19.6% | |
| 7.0% | 6.6% | 6.4% | 6.0% | 2.9% | 4.8% | 6.6% | 8.1% | 8.3% | – | – | – | |
| 46.7% | 49.6% | 51.0% | 51.2% | 41.6% | 33.8% | 35.9% | 36.4% | 29.9% | 0.0% | – | – | |
| 23.5% | 23.0% | 20.6% | 18.5% | 17.4% | 33.1% | 30.1% | 27.6% | 20.9% | 24.4% | 24.7% | 25.2% | |
| 29.5% | 30.4% | 27.0% | 23.1% | 26.5% | 23.4% | 21.7% | 23.2% | 29.0% | 35.3% | 34.7% | 36.1% | |
| 7.9% | 9.2% | 9.8% | 8.1% | 8.8% | 8.7% | 10.3% | 13.4% | 15.7% | 28.7% | 27.2% | 28.0% | |
| 2.4% | 4.0% | 2.1% | 1.0% | 1.5% | 0.1% | 0.4% | 1.6% | 2.8% | 1.5% | 0.8% | – | |
| 3.0% | 2.1% | 2.6% | 2.2% | 2.7% | 3.2% | 3.5% | 5.1% | 7.6% | 11.9% | 11.9% | 11.8% | |
| 16.7% | 14.4% | 12.9% | 12.3% | 14.9% | 6.7% | 3.6% | 4.5% | 9.4% | – | – | – | |
| 70.5% | 69.6% | 73.0% | 76.9% | 73.5% | 76.6% | 78.3% | 76.8% | 71.0% | 64.7% | 65.3% | 63.9% | |
| 3.6% | -2.2% | -1.6% | 0.7% | 7.9% | -16.8% | -23.5% | -28.7% | -39.6% | -124.4% | -153.2% | -174.4% | |
| 4.6% | 5.0% | 5.2% | 5.3% | 4.5% | 6.4% | 6.8% | 7.1% | 7.4% | 12.6% | 14.6% | 15.5% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.